Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PBF-680 by Palo BioFarma for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
PBF-680 is under clinical development by Palo BioFarma and currently in Phase II for Chronic Obstructive Pulmonary Disease (COPD). According...